Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month New Outcomes Research in Patients With Schizophrenia or Bipolar I Disorder to be Presented Published 05-04-21 Submitted by Alkermes DUBLIN, May 4, 2021 /CSRwire/ -- Alkermes plc (Nasdaq: ALKS) recently announced plans to present clinical data and outcomes research from its psychiatry portfolio at three scientific conferences during Mental Health Awareness Month in May. The meetings, all held virtually, include: American Psychiatric Association (APA) Annual Meet...